How much funding has Motus Therapeutics raised?

Motus Therapeutics has raised $25.0M in total funding, most recently a Series B round.

Who are Motus Therapeutics's investors?

Motus Therapeutics's investors include NEA, Allergan.

When was Motus Therapeutics founded?

Motus Therapeutics was founded in 2008.

Where is Motus Therapeutics headquartered?

Motus Therapeutics is headquartered in Boston, Massachusetts, United States.

What industry is Motus Therapeutics in?

Motus Therapeutics operates in Biotech, GI Devices.

How many employees does Motus Therapeutics have?

Motus Therapeutics has 11-50 employees.

Motus Therapeutics

Acquired

Boston, United States · Founded 2008 · $25.0M raised

Biotech

GI Devices

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2008
Business Model: B2B

Total Funding: $25.0M
Last Round: $25.0M Series BJan 2012
Rounds: 2

About

Motus Therapeutics was a Boston-based biotechnology company developing peptide therapeutics for gastrointestinal diseases. Its lead program was relamorelin, a ghrelin agonist for diabetic gastroparesis. Allergan acquired Motus Therapeutics for $200 million upfront in December 2016.

Summary

Motus Therapeutics is a Biotech company based in Boston, United States, founded in 2008. It has raised $25.0M in total across 2 rounds, most recently a $25.0M Series B round in Jan 2012. Investors include NEA and Allergan.